CORVUS PHARMACEUTICALS INC. - COMMON STOCK
8.9500
22-十一月-24 16:44:58
15 分钟延时
股票
+0.0100
+0.11%
今日范围
8.7900 - 9.1900
ISIN
N/A
来源
NASDAQ
-
NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK
26 7月 2024 11:47:58 条件 NetDania Notify
-
25 7月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference
30 5月 2024 16:02:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
06 5月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
02 5月 2024 16:02:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
02 5月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
09 4月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
19 3月 2024 16:02:00 条件 Nasdaq GlobeNewswire
-
13 3月 2024 16:02:00 条件 Nasdaq GlobeNewswire
-
12 2月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
08 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer
06 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell
23 1月 2024 17:00:00 条件 Nasdaq GlobeNewswire
-
09 12月 2023 12:00:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
07 11月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
31 10月 2023 16:02:00 条件 Nasdaq GlobeNewswire
-
06 9月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
08 8月 2023 16:01:00 条件 Nasdaq GlobeNewswire